EP1781657
Lyf með HM74A viðtakavirkni
:
EP Einkaleyfi fallið úr gildi:
10.2.2005:
27.3.2013:
05707363.7
:
10.5.2013:
15.6.2013
:
9.2.2025:
9.2.2018
:
MEDICAMENTS WITH HM74A RECEPTOR ACTIVITY
10.2.2005
27.3.2013
10.5.2013
15.6.2013
9.2.2018
:
GlaxoSmithKline Intellectual Property Development Limited:
980 Great West Road, Brentford, Middlesex TW8 9GS, GB
:
PINTO, Ivan Leo,GlaxoSmithKline:
Harlow, Essex CM19 5AW, GB
:
RAHMAN, Shahzad Sharooq,GlaxoSmithKline:
Harlow, Essex CM19 5AW, GB
:
NICHOLSON, Neville Hubert,GlaxoSmithKline:
Harlow, Essex CM19 5AW, GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
0403282:
14.2.2004:
GB
:
0423562:
22.10.2004:
GB
:
0428375:
24.12.2004:
GB
:
WO2005077950:
10.2.2005
:
C07D 473/04, C07D 473/06, A61K 31/522, A61P 9/00
: 10
: 21.1.2014
: 9.2.2015
: Örn Þór, slf.
: 11
: 16.1.2015
: 9.2.2016
: Örn Þór, slf.
: 12
: 12.1.2016
: 9.2.2017
: Örn Þór, slf.
: 13
: 14.12.2016
: 9.2.2018
: Örn Þór, slf.